-transparent.png){kind=logo}
Flucloxacillin, a new isoxazole penicillin, is active against penicillinase-producing strains of Staphylococcus aureus and is well absorbed in man after oral and intramuscular administration. Compared with isoxazole penicillins in current clinical use-namely, oxacillin, cloxacillin, and dicloxacillin-flucloxacillin has proved as active against Gram-positive cocci, including penicillin-resistant staphylococci. The extent of binding of flucloxacillin to the protein of human serum was similar to that of oxacillin and cloxacillin and less than that of dicloxacillin. In man flucloxacillin given orally produced total and free serum levels higher than those obtained with oxacillin and cloxacillin; total serum levels similar to those of dicloxacillin, and free levels greater than those of dicloxacillin. Similarly, after intramuscular injection the free serum levels of flucloxacillin were higher than those of oxacillin, cloxacillin, and dicloxacillin.
R Sutherland, and
E A Croydon, and
G N Rolinson
September 1970,
The Medical clinics of North America,
R Sutherland, and
E A Croydon, and
G N Rolinson
January 1972,
Clinical pharmacology and therapeutics,
R Sutherland, and
E A Croydon, and
G N Rolinson
April 1968,
Archives of internal medicine,
R Sutherland, and
E A Croydon, and
G N Rolinson
May 1992,
Journal of hepatology,
R Sutherland, and
E A Croydon, and
G N Rolinson
January 1964,
Antimicrobial agents and chemotherapy,
R Sutherland, and
E A Croydon, and
G N Rolinson
January 1964,
Clinical pharmacology and therapeutics,
R Sutherland, and
E A Croydon, and
G N Rolinson
May 1971,
The Journal of antibiotics,
R Sutherland, and
E A Croydon, and
G N Rolinson
September 1965,
Archives of internal medicine,
R Sutherland, and
E A Croydon, and
G N Rolinson
January 1975,
VASA. Zeitschrift fur Gefasskrankheiten,
R Sutherland, and
E A Croydon, and
G N Rolinson
April 1965,
Arzneimittel-Forschung,
